KNYA Med: Financial Breakdown
Decoding financial health metrics of KNYA Med
Total Revenue₹51.1 Cr87%Prev. FY
Total Expenses₹50.4 Cr87%Prev. FY
Profit After Tax₹37.9 Lakh22%Prev. FY
Total Assets₹33.9 Cr80%Prev. FY
Net Profit Margin0.7%-36%Prev. FY
FAQs on Financials of KNYA Med
Yes. In FY25, KNYA Med reported a profit after tax of ₹37.9 Lakh, making it profitable.
KNYA Med's revenue grew 87.8% year-on-year, from ₹27.2 Cr in FY24 to ₹51.1 Cr in FY25.
KNYA Med's estimated EBITDA for FY25 was ₹1.2 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, KNYA Med posted revenue of ₹51.1 Cr (up 87.8% YoY) and a profit after tax of ₹37.9 Lakh. Explore the full financials of KNYA Med here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links